Skip navigation

News

Business Weeklywww.businessweekly.co.uk


GRS Celebrates 1st Birthday in Sweden!

One year on and loving it! In September 2017, GRS established an office at Medicon Village in Lund, Sweden. Our first year there has flown by and as everyone says: "time flies when you're having fun". Well, we must be having loads of fun! We're now looking forward to the coming years supporting our Swedish colleagues and also learning more about Swedish Culture. More »
24 September 2018

Inivata to Present Results at World Conference on Lung Cancer

Inivata, a leader in liquid biopsy today announces that results from its US multi-centre prospective validation study of its InVisionFirst-Lung liquid biopsy test will be presented at the International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (WCLC). More »
24 September 2018

Horizon Discovery Introduces Myeloid DNA Reference Standard to Support Genetic Testing of Leukemia

Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice. More »
24 September 2018

QRC Consultants Welcome Luci Mansfield to the Team

QRCC are pleased to announce the appointment of Lucielle (Luci) Mansfield as Senior Clinical Project Manager More »
24 September 2018

Axol Bioscience Opens US Office

Axol, the rapidly growing specialist in human cell culture, is delighted to announce it has opened a new operational hub in the US. The site which opened for business in Massachusetts on Friday 21st September will help support Axol’s customer base in the United States and Canada. More »
21 September 2018

Domainex Appoints Dr Trevor Perrior as Chief Executive Officer

Domainex Ltd is pleased to announce the appointment of Dr Trevor Perrior as Chief Executive Officer, effective from 1st October 2018. More »
20 September 2018

Novel Deep Learning Drug Discovery Platform gets £1 Million Innovation Boost

Optibrium, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery More »
19 September 2018

AMSBIO: Circulating Tumor DNA Reference Standards

AMSBIO announce the launch of a new range of circulating tumor DNA (ctDNA) Reference Standards for cancer disease management research. More »
19 September 2018

Cambridge Networks: Peer Learning will Benefit New Managers

Are you new to a management role or about to take on management responsibilities? Boost your confidence through collaboration with like-minded people in Cambridge Network's New Managers peer learning group - the newest cohort begins on Wednesday 3rd October. More »
18 September 2018

Discovery Follows Successful Collaboration between Selcia, Cypralis and Gilead Sciences

A paper entitled ‘Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle’ by authors from Selcia, Cypralis and Gilead has been selected as a featured article by the editors of The Journal of Medicinal Chemistry. More »
17 September 2018

<< Previous   Page 1 of 48   Next >>